CT
The startup develops a tissue processing technology that creates strong, durable, and biocompatible tissue matrices from xenogenic sources for soft tissue reinforcement and regenerative applications. This technology provides medical professionals with effective solutions for repairing soft tissue deficiencies and vascular issues in patients.
Updated 3 months ago
Funding
$6.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup develops a tissue processing technology that creates strong, durable, and biocompatible tissue matrices from xenogenic sources for soft tissue reinforcement and regenerative applications. This technology provides medical professionals with effective solutions for repairing soft tissue deficiencies and vascular issues in patients.